- Report
- April 2024
- 683 Pages
Global
From €5308EUR$5,450USD£4,538GBP
- Report
- September 2020
- 700 Pages
Global
From €4772EUR$4,900USD£4,080GBP
- Clinical Trials
- July 2019
- 170 Pages
Global
From €2922EUR$3,000USD£2,498GBP
- Report
- November 2021
- 1032 Pages
Global
From €4870EUR$5,000USD£4,163GBP
- Book
- January 2018
- 272 Pages
- Book
- September 2010
- 418 Pages
- Book
- November 2008
- 288 Pages
The Stem Cell Marker market is a subset of the larger Stem Cells market. It is composed of products and services used to identify, isolate, and characterize stem cells. These markers are used to differentiate stem cells from other cell types, and to identify and track stem cells during research and clinical applications. Stem cell markers are typically proteins, carbohydrates, or other molecules that are expressed on the surface of stem cells.
The Stem Cell Marker market is driven by the increasing demand for stem cell-based therapies and research. The market is expected to grow as the use of stem cells in regenerative medicine and drug discovery increases.
Companies in the Stem Cell Marker market include Merck KGaA, Bio-Rad Laboratories, Thermo Fisher Scientific, Cell Signaling Technology, Abcam, and Miltenyi Biotec. Show Less Read more